Gabelli’s Jonas Says Pharma More Focused on R&D (Audio)

Jeff Jonas, an analyst at Gabelli & Co., says large pharmaceutical firms are "more focused" on research and development, and more new drugs are coming to market. Jonas talks with Bloomberg's Ken Prewitt and Tom Keene on Bloomberg Radio's "Bloomberg Surveillance."

(Source: Bloomberg)

Running time 09:32

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.